Form CORRESP - Correspondence:
SEC Accession No. 0001193125-17-004707
Filing Date
2017-01-06
Accepted
2017-01-06 18:49:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 5765
2 GRAPHIC g286141g84g14.jpg GRAPHIC 52908
  Complete submission text file 0001193125-17-004707.txt   79548
Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations